author_facet Bowie, William R
Ast, Joanne
Sibau, Linda
Shaw, Carol
Jones, Hugh D
Black, William A
Bowie, William R
Ast, Joanne
Sibau, Linda
Shaw, Carol
Jones, Hugh D
Black, William A
author Bowie, William R
Ast, Joanne
Sibau, Linda
Shaw, Carol
Jones, Hugh D
Black, William A
spellingShingle Bowie, William R
Ast, Joanne
Sibau, Linda
Shaw, Carol
Jones, Hugh D
Black, William A
Canadian Journal of Infectious Diseases
Need for Treatment of Gonorrhea to be Effective againstChlamydia trachomatis
Microbiology (medical)
author_sort bowie, william r
spelling Bowie, William R Ast, Joanne Sibau, Linda Shaw, Carol Jones, Hugh D Black, William A 1180-2332 Hindawi Limited Microbiology (medical) http://dx.doi.org/10.1155/1993/613963 <jats:p>Men and women with gonorrhea or contact to gonorrhea are frequently co-infected with<jats:italic>Chlamydia trachomatis</jats:italic>. To assess the importance of using treatment regimens active against both<jats:italic>Neisseria gonorrhoeae</jats:italic>and<jats:italic>C trachomatis</jats:italic>, tetracycline 500 mg orally four times daily for five days, with activity against both organisms, was compared with ceftriaxone, 250 mg once intramuscularly, with activity against only<jats:italic>N gonorrhoeae. N gonorrhoeae</jats:italic>microbiological failure occurred in six of 148 patients (4%) on tetracycline and zero of 85 on ceftriaxone. Microbiological failure for<jats:italic>C trachomatis</jats:italic>occurred in zero of 27 on tetracycline and 10 of 12 (83%) on ceftriaxone (P&lt;0.001). In addition, 14 others on ceftriaxone had<jats:italic>C trachomatis</jats:italic>first isolated after treatment. When all types of microbiologialc and clinical failures are included, outcome was significantly better on tetracycline (P&lt;0.001). Optimal treatment of patients with gonorrhea must include regimens with activity against both<jats:italic>C trachomatis</jats:italic>and<jats:italic>N gonorrhoeae</jats:italic>.</jats:p> Need for Treatment of Gonorrhea to be Effective against<i>Chlamydia trachomatis</i> Canadian Journal of Infectious Diseases
doi_str_mv 10.1155/1993/613963
facet_avail Online
Free
finc_class_facet Biologie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8xOTkzLzYxMzk2Mw
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8xOTkzLzYxMzk2Mw
institution DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-D161
DE-Zwi2
imprint Hindawi Limited, 1993
imprint_str_mv Hindawi Limited, 1993
issn 1180-2332
issn_str_mv 1180-2332
language English
mega_collection Hindawi Limited (CrossRef)
match_str bowie1993needfortreatmentofgonorrheatobeeffectiveagainstchlamydiatrachomatis
publishDateSort 1993
publisher Hindawi Limited
recordtype ai
record_format ai
series Canadian Journal of Infectious Diseases
source_id 49
title Need for Treatment of Gonorrhea to be Effective againstChlamydia trachomatis
title_unstemmed Need for Treatment of Gonorrhea to be Effective againstChlamydia trachomatis
title_full Need for Treatment of Gonorrhea to be Effective againstChlamydia trachomatis
title_fullStr Need for Treatment of Gonorrhea to be Effective againstChlamydia trachomatis
title_full_unstemmed Need for Treatment of Gonorrhea to be Effective againstChlamydia trachomatis
title_short Need for Treatment of Gonorrhea to be Effective againstChlamydia trachomatis
title_sort need for treatment of gonorrhea to be effective against<i>chlamydia trachomatis</i>
topic Microbiology (medical)
url http://dx.doi.org/10.1155/1993/613963
publishDate 1993
physical 347-351
description <jats:p>Men and women with gonorrhea or contact to gonorrhea are frequently co-infected with<jats:italic>Chlamydia trachomatis</jats:italic>. To assess the importance of using treatment regimens active against both<jats:italic>Neisseria gonorrhoeae</jats:italic>and<jats:italic>C trachomatis</jats:italic>, tetracycline 500 mg orally four times daily for five days, with activity against both organisms, was compared with ceftriaxone, 250 mg once intramuscularly, with activity against only<jats:italic>N gonorrhoeae. N gonorrhoeae</jats:italic>microbiological failure occurred in six of 148 patients (4%) on tetracycline and zero of 85 on ceftriaxone. Microbiological failure for<jats:italic>C trachomatis</jats:italic>occurred in zero of 27 on tetracycline and 10 of 12 (83%) on ceftriaxone (P&lt;0.001). In addition, 14 others on ceftriaxone had<jats:italic>C trachomatis</jats:italic>first isolated after treatment. When all types of microbiologialc and clinical failures are included, outcome was significantly better on tetracycline (P&lt;0.001). Optimal treatment of patients with gonorrhea must include regimens with activity against both<jats:italic>C trachomatis</jats:italic>and<jats:italic>N gonorrhoeae</jats:italic>.</jats:p>
container_issue 6
container_start_page 347
container_title Canadian Journal of Infectious Diseases
container_volume 4
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792324958579326986
geogr_code not assigned
last_indexed 2024-03-01T11:57:35.848Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Need+for+Treatment+of+Gonorrhea+to+be+Effective+againstChlamydia+trachomatis&rft.date=1993-01-01&genre=article&issn=1180-2332&volume=4&issue=6&spage=347&epage=351&pages=347-351&jtitle=Canadian+Journal+of+Infectious+Diseases&atitle=Need+for+Treatment+of+Gonorrhea+to+be+Effective+against%3Ci%3EChlamydia+trachomatis%3C%2Fi%3E&aulast=Black&aufirst=William+A&rft_id=info%3Adoi%2F10.1155%2F1993%2F613963&rft.language%5B0%5D=eng
SOLR
_version_ 1792324958579326986
author Bowie, William R, Ast, Joanne, Sibau, Linda, Shaw, Carol, Jones, Hugh D, Black, William A
author_facet Bowie, William R, Ast, Joanne, Sibau, Linda, Shaw, Carol, Jones, Hugh D, Black, William A, Bowie, William R, Ast, Joanne, Sibau, Linda, Shaw, Carol, Jones, Hugh D, Black, William A
author_sort bowie, william r
container_issue 6
container_start_page 347
container_title Canadian Journal of Infectious Diseases
container_volume 4
description <jats:p>Men and women with gonorrhea or contact to gonorrhea are frequently co-infected with<jats:italic>Chlamydia trachomatis</jats:italic>. To assess the importance of using treatment regimens active against both<jats:italic>Neisseria gonorrhoeae</jats:italic>and<jats:italic>C trachomatis</jats:italic>, tetracycline 500 mg orally four times daily for five days, with activity against both organisms, was compared with ceftriaxone, 250 mg once intramuscularly, with activity against only<jats:italic>N gonorrhoeae. N gonorrhoeae</jats:italic>microbiological failure occurred in six of 148 patients (4%) on tetracycline and zero of 85 on ceftriaxone. Microbiological failure for<jats:italic>C trachomatis</jats:italic>occurred in zero of 27 on tetracycline and 10 of 12 (83%) on ceftriaxone (P&lt;0.001). In addition, 14 others on ceftriaxone had<jats:italic>C trachomatis</jats:italic>first isolated after treatment. When all types of microbiologialc and clinical failures are included, outcome was significantly better on tetracycline (P&lt;0.001). Optimal treatment of patients with gonorrhea must include regimens with activity against both<jats:italic>C trachomatis</jats:italic>and<jats:italic>N gonorrhoeae</jats:italic>.</jats:p>
doi_str_mv 10.1155/1993/613963
facet_avail Online, Free
finc_class_facet Biologie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8xOTkzLzYxMzk2Mw
imprint Hindawi Limited, 1993
imprint_str_mv Hindawi Limited, 1993
institution DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Zwi2
issn 1180-2332
issn_str_mv 1180-2332
language English
last_indexed 2024-03-01T11:57:35.848Z
match_str bowie1993needfortreatmentofgonorrheatobeeffectiveagainstchlamydiatrachomatis
mega_collection Hindawi Limited (CrossRef)
physical 347-351
publishDate 1993
publishDateSort 1993
publisher Hindawi Limited
record_format ai
recordtype ai
series Canadian Journal of Infectious Diseases
source_id 49
spelling Bowie, William R Ast, Joanne Sibau, Linda Shaw, Carol Jones, Hugh D Black, William A 1180-2332 Hindawi Limited Microbiology (medical) http://dx.doi.org/10.1155/1993/613963 <jats:p>Men and women with gonorrhea or contact to gonorrhea are frequently co-infected with<jats:italic>Chlamydia trachomatis</jats:italic>. To assess the importance of using treatment regimens active against both<jats:italic>Neisseria gonorrhoeae</jats:italic>and<jats:italic>C trachomatis</jats:italic>, tetracycline 500 mg orally four times daily for five days, with activity against both organisms, was compared with ceftriaxone, 250 mg once intramuscularly, with activity against only<jats:italic>N gonorrhoeae. N gonorrhoeae</jats:italic>microbiological failure occurred in six of 148 patients (4%) on tetracycline and zero of 85 on ceftriaxone. Microbiological failure for<jats:italic>C trachomatis</jats:italic>occurred in zero of 27 on tetracycline and 10 of 12 (83%) on ceftriaxone (P&lt;0.001). In addition, 14 others on ceftriaxone had<jats:italic>C trachomatis</jats:italic>first isolated after treatment. When all types of microbiologialc and clinical failures are included, outcome was significantly better on tetracycline (P&lt;0.001). Optimal treatment of patients with gonorrhea must include regimens with activity against both<jats:italic>C trachomatis</jats:italic>and<jats:italic>N gonorrhoeae</jats:italic>.</jats:p> Need for Treatment of Gonorrhea to be Effective against<i>Chlamydia trachomatis</i> Canadian Journal of Infectious Diseases
spellingShingle Bowie, William R, Ast, Joanne, Sibau, Linda, Shaw, Carol, Jones, Hugh D, Black, William A, Canadian Journal of Infectious Diseases, Need for Treatment of Gonorrhea to be Effective againstChlamydia trachomatis, Microbiology (medical)
title Need for Treatment of Gonorrhea to be Effective againstChlamydia trachomatis
title_full Need for Treatment of Gonorrhea to be Effective againstChlamydia trachomatis
title_fullStr Need for Treatment of Gonorrhea to be Effective againstChlamydia trachomatis
title_full_unstemmed Need for Treatment of Gonorrhea to be Effective againstChlamydia trachomatis
title_short Need for Treatment of Gonorrhea to be Effective againstChlamydia trachomatis
title_sort need for treatment of gonorrhea to be effective against<i>chlamydia trachomatis</i>
title_unstemmed Need for Treatment of Gonorrhea to be Effective againstChlamydia trachomatis
topic Microbiology (medical)
url http://dx.doi.org/10.1155/1993/613963